Cargando…
An Economic Analysis: Is Fidaxomicin Worth the Cost?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905758/ https://www.ncbi.nlm.nih.gov/pubmed/24300041 http://dx.doi.org/10.1093/cid/cit773 |
| _version_ | 1782301381782142976 |
|---|---|
| author | Shah, Hemal Doyle, Joseph J. Belletti, Daniel A. |
| author_facet | Shah, Hemal Doyle, Joseph J. Belletti, Daniel A. |
| author_sort | Shah, Hemal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3905758 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39057582014-02-15 An Economic Analysis: Is Fidaxomicin Worth the Cost? Shah, Hemal Doyle, Joseph J. Belletti, Daniel A. Clin Infect Dis Correspondence Oxford University Press 2014-02-15 /pmc/articles/PMC3905758/ /pubmed/24300041 http://dx.doi.org/10.1093/cid/cit773 Text en © The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Correspondence Shah, Hemal Doyle, Joseph J. Belletti, Daniel A. An Economic Analysis: Is Fidaxomicin Worth the Cost? |
| title | An Economic Analysis: Is Fidaxomicin Worth the Cost? |
| title_full | An Economic Analysis: Is Fidaxomicin Worth the Cost? |
| title_fullStr | An Economic Analysis: Is Fidaxomicin Worth the Cost? |
| title_full_unstemmed | An Economic Analysis: Is Fidaxomicin Worth the Cost? |
| title_short | An Economic Analysis: Is Fidaxomicin Worth the Cost? |
| title_sort | economic analysis: is fidaxomicin worth the cost? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905758/ https://www.ncbi.nlm.nih.gov/pubmed/24300041 http://dx.doi.org/10.1093/cid/cit773 |
| work_keys_str_mv | AT shahhemal aneconomicanalysisisfidaxomicinworththecost AT doylejosephj aneconomicanalysisisfidaxomicinworththecost AT bellettidaniela aneconomicanalysisisfidaxomicinworththecost AT shahhemal economicanalysisisfidaxomicinworththecost AT doylejosephj economicanalysisisfidaxomicinworththecost AT bellettidaniela economicanalysisisfidaxomicinworththecost |